Background: Opium use is one of the common causes of lead toxicity. Lead poisoning can lead to hepatic, hematologic, musculoskeletal, neurological, and cardiovascular damages. In this study, we investigated the reversibility of lead-induced liver damage following chelation therapy.
Methods: We reviewed the medical records of patients with opium-induced lead poisoning regarding elevation in hepatobiliary enzymes level including Alanine Transaminase (ALT), Aspartate Transaminase (AST), and Alkaline Phosphatase (ALP) to normal level and recorded patients’ age, treatment regimen, liver enzymes level before and after treatment; we also investigated other laboratory findings to rule out other causes of liver enzymes increase.
Results: We evaluated 10 male patients with the mean age of 48.3±7.42 years. All patients were referred with the chief complain of abdominal cramps (100%). The mean lead level in patients was 84.48±9.95 µg/dL. The mean serum levels of ALT, AST, and ALP significantly decreased after the treatment with chelating agents ([ALT=117.8±60.22µg/dL-76.9±40.73µg/dL, P=0.022], [AST=100.9±63.96µg/dL-69.9±37.41µg/dL, P=0.028], [ALP=449.8±234.81 µg/dL-338.3±131.22µg/dL, P=0.037]). There was no significant correlation between patients’ lead level and liver enzymes level before and after the treatment.
Conclusion: The results of this study showed that the treatment with chelating agents reverses the liver injury following the lead intoxication.
Dioka C, Orisakwe O, Adeniyi F, Meludu S. Liver and renal function tests in artisans occupationally exposed to lead in mechanic village in Nnewi, Nigeria. International Journal of Environmental Research and Public Health. 2004; 1(1):21-5 [DOI:10.3390/ijerph2004010021]
Verheij J, Voortman J, van Nieuwkerk C, Jarbandhan S, Mulder C, Bloemena E. Hepatic morphopathologic findings of lead poisoning in a drug addict: A case report. Journal of Gastrointestinal and Liver Diseases. 2009; 18(2):225-7.
Mudipalli A. Lead hepatotoxicity & potential health effects. Indian Journal of Medical Research. 2007; 126(6):518-28. [PMID]
Kianoush S, Balali‐Mood M, Mousavi SR, Moradi V, Sadeghi M, Dadpour B, et al. Comparison of therapeutic effects of garlic and d‐Penicillamine in patients with chronic occupational lead poisoning. Basic & clinical Pharmacology & Toxicology. 2012; 110(5):476-81. [DOI:10.1111/j.1742-7843.2011.00841.x]
Mehrpoor O, Farzanezade H. Lead toxicity among oral opium addicts with abdominal pain: A case series of 17 cases. Indian Journal of Forensic Medicine & Toxicology. 2017; 11(2):22-5. [DOI:10.5958/0973-9130.2017.00057.3]
Kim H-C, Jang T-W, Chae H-J, Choi W-J, Ha M-N, Ye B-J, et al. Evaluation and management of lead exposure. Annals of occupational and environmental medicine. 2015; 27(1):30. [DOI:10.1186/s40557-015-0085-9]
Wani AL, Ara A, Usmani JA. Lead toxicity: A review. Interdisciplinary Toxicology. 2015; 8(2):55-64. [DOI:10.1515/intox-2015-0009]
Flora G, Gupta D, Tiwari A. Toxicity of lead: A review with recent updates. Interdisciplinary toxicology. 2012; 5(2):47-58. [DOI:10.2478/v10102-012-0009-2]
Bashandy S. Beneficial effect of combined administration of vitamin C and vitamin E in amelioration of chronic lead hepatotoxicity. Egyptian Journal Of Hospital Medicine. 2006; 23:371-84.
Chang W-J, Joe K-T, Park H-Y, Jeong J-D, Lee D-H. The relationship of liver function tests to mixed exposure to lead and organic solvents. Annals of Occupational and Environmental Medicine. 2013; 25(1):5. [DOI:10.1186/2052-4374-25-5]
Sreeram M, Suryakar AN, Dani NH. Is gamma-glutamyl transpeptidase a biomarker for oxidative stress in periodontitis? Journal of Indian Society of Periodontology. 2015; 19(2):150. [DOI:10.4103/0972-124X.149032]
Thuppil V, Tannir S. Treating lead toxicity: Possibilities beyond synthetic chelation. The Journal of Krishna Institute of Medical Sciences University. 2013; 2(1):4-31.
Aaseth J, Ajsuvakova OP, Skalny AV, Skalnaya MG, Tinkov AA. Chelator combination as therapeutic strategy in mercury and lead poisonings. Coordination Chemistry Reviews. 2018; 358:1-12. [DOI:10.1016/j.ccr.2017.12.011]
Wollheim FA, Lindström CG. Liver abnormalities in penicillamine treated rheumatoid arthritis. Scandinavian Journal of Rheumatology. 1979; 8(suppl. 28):100-5. [DOI:10.3109/03009747909108248]